Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

Study finds mesenchymal stem cells injected into periocular tissue effectively reduce inflammation in the eyes without ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and ...

New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.

Vimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“NurExone” or the “Company”) is pleased to announce the formation of a U.S.-based subsidiary, Exo-Top Inc. (“Exo-Top”), that is ...